Diclofenac May Boost MI Risk in Patients With Spondyloarthritis Diclofenac May Boost MI Risk in Patients With Spondyloarthritis

Risk of myocardial infarction (MI) is increased in patients with spondyloarthritis (SpA) who use the nonsteroidal anti-inflammatory drug (NSAID) diclofenac but not in those who take naproxen, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news